HIND
HIND
NASDAQ · Pharmaceuticals

Vyome Holdings Inc

$2.12
-0.05 (-2.30%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +801.9% upside
Low Target $13.94
Average Target $19.12
High Target $23.15
Current Price $2.12
Current
$2.12
Target
$19.12
$13.94 $19.12 avg $23.15
Scenario Analysis
Bear Case
$13.94
557.5%
Low target
Base Case
$19.12
+801.9%
Avg target
Bull Case
$23.15
+992.0%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$18.60
-88.6% from high
52-Week Low
$1.75
+21.1% from low
Target vs 52W High
$19.12
+2.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%